- Home/
- Article /
- Transition from passive to active targeting of oral insulin nanomedicines: enhancement in bioavailability and glycemic control in diabetes.
Full Author : ['Kaklotar, Dhansukh', 'Agrawal, Poornima', 'Abdulla, Allabakshi', 'Singh, Rahul P', 'Mehata, Abhishesh K', 'Singh, Sanjay', 'Mishra, Brahmeshwar', 'Pandey, Bajarangprasad L', 'Trigunayat, Anshuman', 'Muthu, Madaswamy S']
Journal Title : Nanomedicine (London, England)
Chapter : Section3
Journal Year : 2016
Cited by : Not Available
Oral insulin nanomedicines are effective tools for therapy and management of both Type I and Type II diabetes. This review summarizes the various nanocarriers developed so far in the literature for oral delivery of insulin. It includes lipid-based (i.e., .....
Keywords : ["oral insulin nanomedicine enhancement", "glycemic control", "active targeting", "transition", "passive", "diabetes", "bioavailability"]